Opens in a new tab

Aesculap v Shanghai Bojin Medical Instrument (CFI, 16 October 2026)

Date16 October 2026
CourtCFI
DivisionDüsseldorf (DE) Local Division
Type of actionInfringement Action
Case number(s)UPC_CFI_307/2025
Registry referenceUPC_CFI_307/2025
PartiesAesculap AG v. Shanghai Bojin Medical Instrument Co. Ltd, Shanghai International Holding Corporation GmbH (Europe), Shanghai Bojin Electric Instrument & Device Co., Ltd
LanguageGerman

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 17 October 2026

Our analysis

Summary

By an order of 16 October 2026 (UPC_CFI_307/2025), the Düsseldorf Local Division dismissed Aesculap’s application to rectify its decision on the merits of 1 September 2026 concerning EP 2 892 442 B1. The claimant sought to turn the condition precedent attached to the measures ordered for the United Kingdom into a condition subsequent.

Question

Can the rectification procedure under Rule 353 RoP be used to change the nature of a condition attached to measures ordered by the Court?

Decision

The decision of 1 September 2026 had, among other things, granted an injunction against the second defendant for Germany, France and the United Kingdom. On 29 September 2026, Aesculap applied to rectify point I of the operative part and paras 125(a) and 126 of the grounds, relying on two Court of Appeal decisions. Filed within one month of service, the application was admissible (para. 7). It failed on the merits. Rule 353 RoP covers only clerical errors, errors in calculation and obvious slips, and the passages at issue reflect the Court’s intention, with no translation error (paras 8 and 9). Replacing ‘condition precedent’ with ‘condition subsequent’ would not in any case achieve the desired result, since the condition adopted by the Court of Appeal turns on the absence of a finding that the patent is invalid, and whether the decision is consistent with that case law is not a matter for rectification proceedings (paras 10 to 12).

Key points for practice

Provisions applied

Rules of Procedure
Rule 353 RoP
Case law cited
Court of Appeal, UPC_CoA_312/2025, and Court of Appeal, 13 July 2026, Fujifilm v Kodak (UPC_CoA_473/2025), both relied on by the claimant

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 17 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Patent infringement action, Multi-jurisdictional patent litigation.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
German from the language of proceedings
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_307/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 4 December 2025 Aesculap v Shanghai Bojin Medical Instrument (CFI, 4 December 2025) Generic Order · UPC_CFI_307/2025

    L'audience est fixée au 17 juin 2026 et Shanghai Bojin Electric Instrument & Device est mise en cause. Une solution procédurale est proposée aux parties sur la restitutio et l'extension de l'action.

  2. 27 August 2026 Aesculap v Shanghai Bojin Medical Instrument (CFI, 27 August 2026) Infringement Action · UPC_CFI_307/2025

    La division locale de Düsseldorf confirme la transaction entre Aesculap et deux défenderesses, laisse à chacune ses frais, ordonne la confidentialité des termes et poursuit l'instance contre la troisième.

  3. 1 September 2026 Aesculap v Shanghai Bojin Medical Instrument (CFI, 1 September 2026) Infringement Action · UPC_CFI_307/2025

    La division locale de Düsseldorf juge que les deux fraises reproduisent la revendication 1 et retient la responsabilité d'intermédiaire, et non de contrefacteur, du mandataire européen du fabricant, à qui elle interdit ses services en Allemagne, en France et, sous condition, au Royaume-Uni.

  4. 16 October 2026 Aesculap v Shanghai Bojin Medical Instrument (CFI, 16 October 2026) Infringement Action · UPC_CFI_307/2025

What the record states

Nature of the act
Infringement Action
Outcome (Dhenne Avocats summary)
La division locale de Düsseldorf déclare recevable mais rejette la demande d’Aesculap tendant à rectifier la condition assortissant les mesures prononcées pour le Royaume-Uni.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 892 442
Surgical, torque-transmitting instrument including associated tool
recorded proprietor: Aesculap AG
Mentioned in the analysis (role not qualified)
Also mentioned in 8 other decision(s): Aesculap v Shanghai Bojin Medical Instrument (CFI, 1 September 2026) · Aesculap v Shanghai Bojin Medical Instrument (CFI, 27 August 2026) · Aesculap v Shanghai Bojin Medical Instrument (CFI, 4 December 2025) · Aesculap v Shanghai International Holding Corporation (Europe) (CFI, 3 · Aesculap v Shanghai International Holding Corporation (Europe) (CFI, 1 · Aesculap v Shanghai International Holding (CFI, 23 June 2025) · Aesculap v Shanghai International (Eur) (CFI, 10 June 2025) · Aesculap v Shanghai International Holding (CFI, 1 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.